Professor Arora's group has pioneered the synthesis of drug candidates and is using their expertise to develop compounds that block viral entry.
A doctoral candidate, Gordon is developing peptide inhibitors of coronavirus-host cell infusion with the goal of rapidly developing antiviral peptides.
Shuhui's doctoral research focuses on studying the critical role of glycosylation in influenza pathogensis. Understanding the cause of influenza severity will help researchers and pharmaceuticals develop effective drugs to treat the disease and may explain the differential susceptibility to infection between different age groups.
A doctoral candidate, Seong-Ho is designing compounds to inhibit coronavirus entry into human cells.
Professor Lupoli's Lab is testing the ability of clinically-approved drug molecules to disable a protein that the SARS-CoV-2 virus uses to replicate and modify its genetic material.
Frank Marrone III
In collaboration with the Department of Anthropology, Frank, a doctoral candidate in the Department of Chemistry, uses computational tools to analyze how SARS-CoV-2 interacts with different animal species at the molecular level to modify how we interact with these species during the course of the pandemic.
A doctoral candidate, Rushna is part of a lab that develops a simple, fast, and cost-effective diagnostic method for testing biological samples for viral infection with the goal of testing for viral antigens in order to address the COVID-19 pandemic in the immediate future.
Chao is a doctoral candidate who uses computational drug discovery methods to help expedite the drug discovery process.
A doctoral candidate, Daniel is developing ACE2 mimics to target the coronavirus spike protein.